301111.SHE Guangdong Lifestrong Pharmacy Co. Ltd.
- Market cap
- CNY 2.58B
- P/E
- 402.5x
- P/B
- 3.45x
- ROE
- 0.5%
- Dividend yield
- 0.31%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is 301111.SHE undervalued?
Graham numberThe Graham number of Guangdong Lifestrong Pharmacy Co. Ltd. cannot be estimated reliably (the estimate is too far from the market price).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Guangdong Lifestrong Pharmacy Co. Ltd. fundamental analysis
No fundamental analysis for Guangdong Lifestrong Pharmacy Co. Ltd. yet.
Guangdong Lifestrong Pharmacy Co. Ltd. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Guangdong Lifestrong Pharmacy Co. Ltd.
Guangdong Lifestrong Pharmacy Co., Ltd. engages in the research, development, production, and sale of pharmaceutical products. It operates through Medical Services and Health Management; and Health Consumer Products segments. The company produces tablets, hard capsules, injections, and pills, and other related products. It also offers respiratory, pediatric, gynecology, urinary, and nutrition and healthcare category products. Guangdong Lifestrong Pharmacy Co., Ltd. was found…
Full company profileGuangdong Lifestrong Pharmacy Co. Ltd. financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Guangdong Lifestrong Pharmacy Co. Ltd. annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 192M | 290M | 317M | 341M | 350M | 283M | 292M | 279M | 315M | 283M |
| Gross Profit | 104M | 201M | 229M | 226M | 242M | 191M | 198M | 190M | 191M | 154M |
| Operating Income | 38.5M | 74.6M | 84.2M | 72.7M | 70.3M | 43.1M | 41.2M | 884K | -18.1M | -1.33M |
| EBITDA | 75.3M | 86.6M | 89.0M | 84.0M | 81.0M | 46.1M | 48.4M | 13.1M | 11.6M | 5.80M |
| Net Income | 32.8M | 63.6M | 66.6M | 62.5M | 57.2M | 33.4M | 33.5M | 4.16M | -4.49M | 4.00M |
| EPS | 0.27 | 0.53 | 0.56 | 0.52 | 0.48 | 0.21 | 0.21 | 0.03 | -0.03 | 0.03 |
| Balance Sheet | ||||||||||
| Total Assets | 281M | 298M | 325M | 384M | 826M | 857M | 856M | 933M | 894M | 916M |
| Total Liabilities | 115M | 67.6M | 53.6M | 60.4M | 75.3M | 98.4M | 77.3M | 166M | 143M | 140M |
| Shareholders' Equity | 166M | 230M | 272M | 323M | 751M | 759M | 776M | 764M | 751M | 746M |
| Cash & Short-term Investments | 95.0M | 94.0M | 102M | 134M | 554M | 261M | 204M | 194M | 143M | 342M |
| Total Debt | 46.7M | - | - | - | 1.09M | 159K | 14.0M | 72.2M | - | - |
| Cash Flow | ||||||||||
| Operating Cash Flow | 7.04M | 41.4M | 48.7M | 90.9M | 71.6M | 69.9M | -12.8M | 3.21M | 10.6M | - |
| Capital Expenditure | 1.65M | 1.35M | 12.8M | 46.1M | 3.09M | 5.54M | 38.6M | 37.9M | 9.78M | 20.1M |
| Free Cash Flow | 5.40M | 40.0M | 35.9M | 44.8M | 68.5M | 64.3M | -51.4M | -34.7M | 803K | -31.1M |
| Ratios | ||||||||||
| ROE | 19.7% | 27.7% | 24.5% | 19.3% | 7.6% | 4.4% | 4.3% | 0.5% | -0.6% | 0.5% |
| ROA | 11.7% | 21.4% | 20.5% | 16.3% | 6.9% | 3.9% | 3.9% | 0.4% | -0.5% | 0.4% |
| Net Profit Margin | 17.1% | 21.9% | 21.0% | 18.3% | 16.3% | 11.8% | 11.5% | 1.5% | -1.4% | 1.4% |
| Debt to Equity | 0.28x | - | - | - | 0.00x | 0.00x | 0.02x | 0.09x | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Guangdong Lifestrong Pharmacy Co. Ltd. dividends
- Dividend yield
- 0.31%
- Forward dividend
- 0.05 CNY
- Payout ratio
- -
- Ex-dividend date
- Jun 11, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | CNY 8.00M | 0.05 | - |
| 2024 | CNY 16.0M | 0.12 | 384.4% |
| 2023 | CNY 16.0M | 0.10 | 47.8% |
| 2022 | CNY 25.6M | 0.16 | 76.6% |
| 2021 | - | - | - |
| 2020 | CNY 10.8M | 0.09 | 17.3% |
| 2019 | CNY 30.0M | 0.25 | 45.0% |
| 2018 | 765K | 0.01 | 1.2% |
| 2017 | 47.7M | 0.40 | 145.5% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Guangdong Lifestrong Pharmacy Co. Ltd.
- Insiders 49.41%
- Institutions 6.65%
- Public & others 43.95%
- Shares outstanding 160M
- Free float 89.4M
Guangdong Lifestrong Pharmacy Co. Ltd. company profile
- Company name
- Guangdong Lifestrong Pharmacy Co. Ltd.
- Ticker
- 301111.SHE
- ISIN
- CNE1000054T7
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Pharmaceuticals
- Employees
- 578
- Fiscal year end
- December
- Address
- No. 08, Block 16th, Shantou, China, 515064
- Phone
- 86 754 8811 9888
- Website
- wnqzy.com.cn
About Guangdong Lifestrong Pharmacy Co. Ltd.
Guangdong Lifestrong Pharmacy Co., Ltd. engages in the research, development, production, and sale of pharmaceutical products. It operates through Medical Services and Health Management; and Health Consumer Products segments. The company produces tablets, hard capsules, injections, and pills, and other related products. It also offers respiratory, pediatric, gynecology, urinary, and nutrition and healthcare category products. Guangdong Lifestrong Pharmacy Co., Ltd. was founded in 1951 and is headquartered in Shantou, China.
Guangdong Lifestrong Pharmacy Co. Ltd. management
4- Mr. Ou XiantaoCEO & Chairman of the Board · born 1961
- Mr. Xiuyan ChenVP, CFO, Board Secretary & Director · born 1975
- Mr. Zeqing OuVP & Director · born 1989
- Xing Yu ChenAccounting Supervisor